CN107595459A - 颞颌关节恢复装置 - Google Patents
颞颌关节恢复装置 Download PDFInfo
- Publication number
- CN107595459A CN107595459A CN201711060612.XA CN201711060612A CN107595459A CN 107595459 A CN107595459 A CN 107595459A CN 201711060612 A CN201711060612 A CN 201711060612A CN 107595459 A CN107595459 A CN 107595459A
- Authority
- CN
- China
- Prior art keywords
- temporomandibular joint
- recovery device
- panel
- headband
- joint recovery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000001738 temporomandibular joint Anatomy 0.000 title claims abstract description 69
- 238000011084 recovery Methods 0.000 title claims abstract description 30
- 239000003814 drug Substances 0.000 claims abstract description 56
- 239000004744 fabric Substances 0.000 claims description 24
- 235000010254 Jasminum officinale Nutrition 0.000 claims description 22
- 240000005385 Jasminum sambac Species 0.000 claims description 22
- 241000361919 Metaphire sieboldi Species 0.000 claims description 16
- 240000008397 Ganoderma lucidum Species 0.000 claims description 15
- 244000124853 Perilla frutescens Species 0.000 claims description 15
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims description 14
- 235000003097 Artemisia absinthium Nutrition 0.000 claims description 14
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims description 14
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 14
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 14
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 14
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims description 14
- 239000001138 artemisia absinthium Substances 0.000 claims description 14
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 14
- 240000004638 Dendrobium nobile Species 0.000 claims description 13
- 235000004347 Perilla Nutrition 0.000 claims description 13
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 12
- 235000018905 epimedium Nutrition 0.000 claims description 12
- 235000008397 ginger Nutrition 0.000 claims description 12
- 235000008434 ginseng Nutrition 0.000 claims description 12
- 241000576429 Forsythia suspensa Species 0.000 claims description 11
- 244000194101 Ginkgo biloba Species 0.000 claims description 11
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 11
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 11
- 240000008042 Zea mays Species 0.000 claims description 11
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims description 10
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims description 10
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 10
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 10
- 239000002775 capsule Substances 0.000 claims description 10
- 235000008384 feverfew Nutrition 0.000 claims description 10
- 235000009328 Amaranthus caudatus Nutrition 0.000 claims description 9
- 241001146155 Emilia Species 0.000 claims description 9
- 235000019049 Emilia coccinea Nutrition 0.000 claims description 9
- 241001016310 Epimedium grandiflorum Species 0.000 claims description 9
- 235000011201 Ginkgo Nutrition 0.000 claims description 8
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 8
- 235000005822 corn Nutrition 0.000 claims description 8
- 230000033001 locomotion Effects 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 238000000926 separation method Methods 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 240000001851 Artemisia dracunculus Species 0.000 claims 1
- 244000192528 Chrysanthemum parthenium Species 0.000 claims 1
- 244000131316 Panax pseudoginseng Species 0.000 claims 1
- 244000273928 Zingiber officinale Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 45
- 230000000259 anti-tumor effect Effects 0.000 abstract description 9
- 230000001225 therapeutic effect Effects 0.000 abstract description 9
- 238000002512 chemotherapy Methods 0.000 abstract description 4
- 238000010276 construction Methods 0.000 abstract description 3
- 230000008030 elimination Effects 0.000 abstract description 2
- 238000003379 elimination reaction Methods 0.000 abstract description 2
- 210000004369 blood Anatomy 0.000 description 33
- 239000008280 blood Substances 0.000 description 33
- 210000004185 liver Anatomy 0.000 description 32
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 29
- 201000010099 disease Diseases 0.000 description 27
- 210000004072 lung Anatomy 0.000 description 23
- 206010028980 Neoplasm Diseases 0.000 description 20
- 208000002193 Pain Diseases 0.000 description 20
- 230000036407 pain Effects 0.000 description 20
- 238000011282 treatment Methods 0.000 description 18
- 201000011510 cancer Diseases 0.000 description 17
- 230000007812 deficiency Effects 0.000 description 16
- 230000006870 function Effects 0.000 description 16
- 210000003734 kidney Anatomy 0.000 description 16
- 208000006673 asthma Diseases 0.000 description 15
- 230000004438 eyesight Effects 0.000 description 15
- 240000006891 Artemisia vulgaris Species 0.000 description 13
- 235000009508 confectionery Nutrition 0.000 description 13
- 244000025254 Cannabis sativa Species 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 12
- 229940079593 drug Drugs 0.000 description 12
- 210000002784 stomach Anatomy 0.000 description 12
- 206010011224 Cough Diseases 0.000 description 11
- 240000004371 Panax ginseng Species 0.000 description 11
- 241000234314 Zingiber Species 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 11
- 238000001959 radiotherapy Methods 0.000 description 11
- 206010047700 Vomiting Diseases 0.000 description 10
- 239000010839 body fluid Substances 0.000 description 10
- 239000000284 extract Substances 0.000 description 10
- 239000000796 flavoring agent Substances 0.000 description 10
- 235000019634 flavors Nutrition 0.000 description 10
- 206010019233 Headaches Diseases 0.000 description 9
- 206010030113 Oedema Diseases 0.000 description 9
- 208000004880 Polyuria Diseases 0.000 description 9
- 240000004460 Tanacetum coccineum Species 0.000 description 9
- 210000001124 body fluid Anatomy 0.000 description 9
- 230000004087 circulation Effects 0.000 description 9
- 230000035619 diuresis Effects 0.000 description 9
- 208000002173 dizziness Diseases 0.000 description 9
- 235000007516 Chrysanthemum Nutrition 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 8
- 240000002853 Nelumbo nucifera Species 0.000 description 8
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 8
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 8
- 238000010586 diagram Methods 0.000 description 8
- 239000003205 fragrance Substances 0.000 description 8
- 231100000869 headache Toxicity 0.000 description 8
- 241000411851 herbal medicine Species 0.000 description 8
- 231100000614 poison Toxicity 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 244000286838 Eclipta prostrata Species 0.000 description 7
- 235000003434 Sesamum indicum Nutrition 0.000 description 7
- 210000000038 chest Anatomy 0.000 description 7
- 230000006378 damage Effects 0.000 description 7
- 210000003414 extremity Anatomy 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 210000000214 mouth Anatomy 0.000 description 7
- 230000004224 protection Effects 0.000 description 7
- 238000005728 strengthening Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 230000000202 analgesic effect Effects 0.000 description 6
- 230000033228 biological regulation Effects 0.000 description 6
- 235000013399 edible fruits Nutrition 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 230000036039 immunity Effects 0.000 description 6
- 230000001939 inductive effect Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 239000003053 toxin Substances 0.000 description 6
- 231100000765 toxin Toxicity 0.000 description 6
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 5
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 5
- 241001573881 Corolla Species 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 5
- 208000008454 Hyperhidrosis Diseases 0.000 description 5
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 5
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 5
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 5
- 244000269722 Thea sinensis Species 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 230000027939 micturition Effects 0.000 description 5
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 5
- 210000005036 nerve Anatomy 0.000 description 5
- 239000002574 poison Substances 0.000 description 5
- 230000001681 protective effect Effects 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 230000008673 vomiting Effects 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 206010002383 Angina Pectoris Diseases 0.000 description 4
- 235000010894 Artemisia argyi Nutrition 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 206010019468 Hemiplegia Diseases 0.000 description 4
- 244000040738 Sesamum orientale Species 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 4
- 230000003712 anti-aging effect Effects 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 230000007937 eating Effects 0.000 description 4
- 230000001900 immune effect Effects 0.000 description 4
- 201000001881 impotence Diseases 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 231100000252 nontoxic Toxicity 0.000 description 4
- 230000003000 nontoxic effect Effects 0.000 description 4
- 230000001151 other effect Effects 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 210000002345 respiratory system Anatomy 0.000 description 4
- 235000014347 soups Nutrition 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 230000010415 tropism Effects 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- 239000011800 void material Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 241000131317 Capitulum Species 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 240000005250 Chrysanthemum indicum Species 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 241000424773 Epimedium alpinum Species 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 244000000231 Sesamum indicum Species 0.000 description 3
- 206010046788 Uterine haemorrhage Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 244000030166 artemisia Species 0.000 description 3
- 208000034158 bleeding Diseases 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 230000000711 cancerogenic effect Effects 0.000 description 3
- 231100000315 carcinogenic Toxicity 0.000 description 3
- 210000003169 central nervous system Anatomy 0.000 description 3
- 230000000973 chemotherapeutic effect Effects 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 230000007368 endocrine function Effects 0.000 description 3
- 206010015037 epilepsy Diseases 0.000 description 3
- 239000000469 ethanolic extract Substances 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 208000021760 high fever Diseases 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 238000002386 leaching Methods 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 235000021251 pulses Nutrition 0.000 description 3
- 230000002285 radioactive effect Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000008093 supporting effect Effects 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 206010002368 Anger Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- -1 Coumarin glucoside Chemical class 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 241000026010 Dendrobium candidum Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000255925 Diptera Species 0.000 description 2
- 206010013952 Dysphonia Diseases 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000010412 Glaucoma Diseases 0.000 description 2
- 208000010473 Hoarseness Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 241000207840 Jasminum Species 0.000 description 2
- 235000007457 Jasminum sambac Nutrition 0.000 description 2
- BTJXBZZBBNNTOV-UHFFFAOYSA-N Linalyl benzoate Chemical compound CC(C)=CCCC(C)(C=C)OC(=O)C1=CC=CC=C1 BTJXBZZBBNNTOV-UHFFFAOYSA-N 0.000 description 2
- 206010025421 Macule Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 206010034960 Photophobia Diseases 0.000 description 2
- 208000012287 Prolapse Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- VQKFNUFAXTZWDK-UHFFFAOYSA-N alpha-methylfuran Natural products CC1=CC=CO1 VQKFNUFAXTZWDK-UHFFFAOYSA-N 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 210000002565 arteriole Anatomy 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 238000000429 assembly Methods 0.000 description 2
- 230000000712 assembly Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000000748 cardiovascular system Anatomy 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000002279 cholagogic effect Effects 0.000 description 2
- 230000001989 choleretic effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 210000002455 dental arch Anatomy 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 208000013219 diaphoresis Diseases 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000012259 ether extract Substances 0.000 description 2
- 210000001508 eye Anatomy 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 230000000762 glandular Effects 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- IRHTZOCLLONTOC-UHFFFAOYSA-N hexacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCO IRHTZOCLLONTOC-UHFFFAOYSA-N 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 239000010977 jade Substances 0.000 description 2
- 210000001847 jaw Anatomy 0.000 description 2
- 230000009916 joint effect Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000001665 lethal effect Effects 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 201000007270 liver cancer Diseases 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 208000014018 liver neoplasm Diseases 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 235000009973 maize Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000000554 physical therapy Methods 0.000 description 2
- 238000011321 prophylaxis Methods 0.000 description 2
- 230000009993 protective function Effects 0.000 description 2
- 230000001012 protector Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- MBDOYVRWFFCFHM-SNAWJCMRSA-N (2E)-hexenal Chemical compound CCC\C=C\C=O MBDOYVRWFFCFHM-SNAWJCMRSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- UUTKICFRNVKFRG-WDSKDSINSA-N (4R)-3-[oxo-[(2S)-5-oxo-2-pyrrolidinyl]methyl]-4-thiazolidinecarboxylic acid Chemical compound OC(=O)[C@@H]1CSCN1C(=O)[C@H]1NC(=O)CC1 UUTKICFRNVKFRG-WDSKDSINSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- MUKYLHIZBOASDM-UHFFFAOYSA-N 2-[carbamimidoyl(methyl)amino]acetic acid 2,3,4,5,6-pentahydroxyhexanoic acid Chemical compound NC(=N)N(C)CC(O)=O.OCC(O)C(O)C(O)C(O)C(O)=O MUKYLHIZBOASDM-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 241000282452 Ailuropoda melanoleuca Species 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 244000141218 Alpinia officinarum Species 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 241001435059 Artemisia argyi Species 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 206010003497 Asphyxia Diseases 0.000 description 1
- 241000208837 Asterales Species 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 244000056139 Brassica cretica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 244000062995 Cassia occidentalis Species 0.000 description 1
- 235000001948 Cassia occidentalis Nutrition 0.000 description 1
- 244000201986 Cassia tora Species 0.000 description 1
- 235000014552 Cassia tora Nutrition 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 241001523681 Dendrobium Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241001362421 Epimedium brevicornu Species 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 206010064503 Excessive skin Diseases 0.000 description 1
- 208000004929 Facial Paralysis Diseases 0.000 description 1
- 108010088842 Fibrinolysin Proteins 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 241000555712 Forsythia Species 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 241001113926 Gelsemium Species 0.000 description 1
- 244000224182 Gomphrena globosa Species 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010021928 Infertility female Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- XPPALVZZCMPTIV-ARJAWSKDSA-N Jasmine lactone Chemical compound CC\C=C/CC1CCCC(=O)O1 XPPALVZZCMPTIV-ARJAWSKDSA-N 0.000 description 1
- XPPALVZZCMPTIV-UHFFFAOYSA-N Jasmine lactone Natural products CCC=CCC1CCCC(=O)O1 XPPALVZZCMPTIV-UHFFFAOYSA-N 0.000 description 1
- XMLSXPIVAXONDL-PLNGDYQASA-N Jasmone Chemical compound CC\C=C/CC1=C(C)CCC1=O XMLSXPIVAXONDL-PLNGDYQASA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 241000830535 Ligustrum lucidum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 241000207834 Oleaceae Species 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 241000904014 Pappus Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 235000004348 Perilla frutescens Nutrition 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011615 Pinus koraiensis Nutrition 0.000 description 1
- 240000007263 Pinus koraiensis Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010048899 Radiation oesophagitis Diseases 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 241000238370 Sepia Species 0.000 description 1
- 238000003457 Shi epoxidation reaction Methods 0.000 description 1
- 241000607760 Shigella sonnei Species 0.000 description 1
- 244000111146 Sonchus arvensis Species 0.000 description 1
- 235000008132 Sonchus arvensis ssp. uliginosus Nutrition 0.000 description 1
- 235000010586 Sophora japonica Nutrition 0.000 description 1
- 244000046101 Sophora japonica Species 0.000 description 1
- 244000046109 Sorghum vulgare var. nervosum Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 240000006909 Tilia x europaea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 241001533104 Tribulus terrestris Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 208000036826 VIIth nerve paralysis Diseases 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000003679 aging effect Effects 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 238000004380 ashing Methods 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 238000009412 basement excavation Methods 0.000 description 1
- 210000003323 beak Anatomy 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 208000020670 canker sore Diseases 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 206010007625 cardiogenic shock Diseases 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 231100000244 chromosomal damage Toxicity 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 229940001501 fibrinolysin Drugs 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 230000000025 haemostatic effect Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- TZJALUIVHRYQQB-XLRXWWTNSA-N icariin Chemical compound C1=CC(OC)=CC=C1C1=C(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)C(=O)C2=C(O)C=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-XLRXWWTNSA-N 0.000 description 1
- TZJALUIVHRYQQB-UHFFFAOYSA-N icariine Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(C)O2)O)C(=O)C2=C(O)C=C(OC3C(C(O)C(O)C(CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-UHFFFAOYSA-N 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000005918 in vitro anti-tumor Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 239000001675 jasminum grandiflorum l. oil Substances 0.000 description 1
- 230000037231 joint health Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 208000027906 leg weakness Diseases 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 201000010260 leiomyoma Diseases 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 108010070324 lumbrokinase Proteins 0.000 description 1
- 239000009064 mailuoning Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 230000018984 mastication Effects 0.000 description 1
- 238000010077 mastication Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 231100000590 oncogenic Toxicity 0.000 description 1
- 230000002246 oncogenic effect Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 244000112814 pipewort Species 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 208000006934 radiodermatitis Diseases 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 230000035936 sexual power Effects 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- XMLSXPIVAXONDL-UHFFFAOYSA-N trans-jasmone Natural products CCC=CCC1=C(C)CCC1=O XMLSXPIVAXONDL-UHFFFAOYSA-N 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- 210000001260 vocal cord Anatomy 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及医疗器械技术领域,特别是一种颞颌关节恢复装置,包括头带、耳托面板、颞颌关节面板和下颌托板,所述头带、耳托面板和颞颌关节面板均为左右对称两个,所述耳托面板的一端与头带连接,另一端与颞颌关节面板的上部,所述左右颞颌关节面板的下部均与下颌托板紧固连接,所述头带的左右末端还设有连接装置,本发明药垫内放入了抗肿瘤以及消除化疗后的副作用的配方,本发明具有结构简单,操作方便,治疗效果好等特点。
Description
技术领域
本发明涉及医疗器械技术领域,特别是一种颞颌关节恢复装置。
背景技术
肿瘤(Tumor) 是机体在各种致癌因素作用下,局部组织的某一个细胞在基因水平上失去对其生长的正常调控,导致其克隆性异常增生而形成的异常病变而产生的,20世纪后期近30年以来癌症发病一直呈上升的趋势,据世界卫生组织(WHO)报告,1990年全球癌症新发病例数约807万,比1975年的517万增加了37.4%,而1997年全球的癌症死亡数约620万,并且按目前的趋势预测,至2020年随着世界人口达80亿,将有2000万新发癌症病例,其中死亡人数将达1200万,且其中绝大部分将发生在发展中国家;几十年来,由于生态环境的不断恶化、艾滋病等疾病的传播,恶性肿瘤的发病率呈上升趋势,并成为继心血管疾病之后的第二大致死病因。目前,对肿瘤的治疗手段有显著进步,但对危害人类生命健康最严重的、占恶性肿瘤90%以上的实体瘤的治疗尚未能达到令人满意的效果。肿瘤是机体组织细胞,在不同致癌因素长期作用下,发生一系列过度的,不协调的增生和异常分化而形成的病变,即使致癌因素停止作用后,仍然继续过度生长。其外形常表现为肿块,一般为良性与恶性两种。由于肿瘤的病因繁多,病种不一,临床表现多端,所以病理变化也是非常复杂的,并非孤立和单一的。近代中医学认为,恶性肿瘤(癌症)的病机大约有阴阳失调、气滞血痴、痔结湿聚,热毒内蕴、气血亏虚等引起,最终会造成机体的各种功能紊乱,如内分泌失调,脂肪代谢失调、免疫***功能下降等,导致肿瘤的发生。因此,肿瘤学一直是医学研究的重点,寻找有效的抗肿瘤药物与方法,彻底攻克肿瘤是世界医学界的重要研究课题。目前***有药物治疗、放疗和化疗,特别是放疗,是癌症三大治疗手段之一。是用各种不同能量的射线照射肿瘤,以抑制和杀灭癌细胞的一种治疗方法。放疗就是放射治疗,指用射线消除病灶,但是放疗会产生放射性皮炎、放射性食管炎以及食欲下降、恶心、呕吐、腹痛、腹泻或便秘等诸多毒副反应,化疗后对身体免疫力影响也较大,身体情况也受到很大损伤,特别是对口腔癌、食道癌和鼻咽癌的放疗后,由于颞颌关节活动不利,患者口腔张合受到了很大的影响,它涉及列咀嚼肌群和颞下颌关节,主要表现为长期的关节疼痛,关节弹向和下颌运动功能紊乱,严重影响咀嚼功能和言语。目前常采用的患处贴膏药或是一些理疗器具进行辅助治疗,其治疗效果不确定,且病程长,患者也不能长期坚持每天到医院进行理疗。所以,近年来一些医学机构和医务工作者发发明了一些用于颞颌关节活动专用的医疗器械,例如:
1.中国专利:一种颞颌关节开合锻炼器,申请号:CN201420629753.4,申请日期:2014.10.29,专利权人:河南省洛阳正骨医院河南省骨科医院,发明人:胡沛,宋晓征,韩松辉,韩壮羽,王逸凡,摘要:公开了一种用于颞颌关节的矫形器具,包括:上齿支撑件和下齿支撑件,上齿支撑件和下齿支撑件中的每一者都包括对应于前齿的前齿弓部分,和彼此面对并且对应于臼齿区域的、从前齿弓部分延伸的一对后腿部;至少一组上枢转件和下枢转件,所述至少一组上枢转件和下枢转件分别地联接到上齿支撑件和下齿支撑件并且可在向前、向后、向左和向右方向中的至少一个方向上转动;和连接构件,所述连接构件连接上枢转件和下枢转件并且调节上枢转件和下枢转件之间的空间。因而易于调节上齿支撑件和下齿支撑件之间的水平方向上的相对运动以及高度。
2.中国专利:颞颌关节训练器,申请号:CN201611251522.4,申请日期:2016.12.29,专利权人:山东威高集团医用高分子制品股份有限公司,发明人:祁晓娜,;姚强,王飞,夏承强,摘要:该发明提供颞颌关节训练器,包括支撑部和身部,支撑部包括分别与上下牙弓相符的两个半环形的叉板、两个连接臂和两个支臂,叉板的中部分别设有叉板柄,叉板柄的一端与叉板的外圆边缘相连接,叉板柄的另一端分别与连接臂的前端通过前连接销铰接,连接臂的后端分别与支臂的前端通过后连接销铰接,所述身部包括壳体、滑套、滑芯、弹簧、压力调节螺母、压力调节螺杆和位置调节螺母。该发明的有益效果是不需手握或按压力量,只要调整好相应的开口距离和开口弹力,通过病人自主咬合力,使上下颌闭合,再通过弹簧弹力辅助病人张开口,实现下颌往复上下运动,病人轻松舒适。
3.中国专利:颞颌关节紊乱康复器,申请号:CN201320022114.7,申请日期:2013.01.16,专利权人:深圳市宝安区人民医院,摘要:该实用新型是一种颞颌关节紊乱康复器,包括颞颌护具本体和永磁铁;所述的颞颌护具本体包括弓形架和左、右前耳贴;所述的左、右耳前贴设于弓形架的两端;所述的永磁铁分别设于左、右耳前贴内;属于医疗设备技术领域。目的是提供一种设计精致巧妙,更加趋近于人性化的设计理念,即可达到安全、舒心和放心多重效果,同时由于该颞颌关节紊乱康复器携带有永磁铁,可在短的时间内使颞颌关节尽快恢复,且同时具有节能环保、经济实惠而且不受时间地点限制的康复器
本发明人在工作实践中发现,以上公开的文献虽然对颞颌关节的恢复起着一定的作用,但是,还存一些问题,如文献1和文献2需要将仪器放入患者口中,让人感觉恶心呕吐,而文献3虽然不用放入口腔内,然而,该康复器以及市面上的治疗仪器均存在一定的通性,即治疗仪器的治疗效果均达不到人们预见的效果。因此,如何设计一种让患者能够接受且疗效突出的颞颌关节恢复装置,是本领域技术人员亟待解决的难题。
发明内容
本发明的目的在于克服现有技术中的缺陷与不足,提供一种结构简单,效果显著的使得患者欣然接受,且能对癌症患者的治疗以及放疗后产生不同程度副作用起到治疗作用的颞颌关节恢复装置。
本发明的目的是这样实现的:
本发明的颞颌关节恢复装置,包括头带、耳托面板、颞颌关节面板和下颌托板,所述头带、耳托面板和颞颌关节面板均为左右对称两个,所述耳托面板的一端与头带连接,另一端与颞颌关节面板的上部,所述左右颞颌关节面板的下部均与下颌托板紧固连接,所述头带的左右末端还设有连接装置。
优选的,所述的耳托面板包括面料以及设于面料内部的柔软垫。
优选的,所述的颞颌关节面板包括面料以及设于面料6内部的药垫。
优选的,所述的下颌托板包括面料以及设于面料内部的柔软垫,在所述柔软垫下底面还安装有底板,在所述底板上设有至少个弹簧组件。
优选的,所述的连接装置的结构为能调节距离并实现分离或定位的旋钮齿轮齿条调节机构、魔术贴、齿状扣带、卡扣、磁性贴中的任意一种。
优选的,所述的药垫,其配方按重量比分为:灵芝10-16,人参2-5、银杏叶3-6、石斛5-10、淫羊藿6-12、地龙3-8、艾草8-12、风姜6-8、一点红10-15、旱连草8-10、白菊花6-10、决明子5-8、玉米须12-15、连翘6-10、紫苏8-10、茉莉花10-20。
优选的,所述的药垫,其制作方法是将所述配方的新鲜生草洗净打碎直接制成的药垫。
优选的,所述的药垫8,其制作方法是将所述配方洗净晒干打碎成粉状制成的药垫。
优选的,所述的弹簧组件,其中弹簧的直径是0.2~2mm。
优选的,所述的下颌托板4的底部还设有支撑托架,用于方便双手托住或架于桌面上,所述支撑托架的长短是固定式或是伸缩式结构,根据个人需要可以进行调节。
上述技术方案中:
灵芝,拉丁文名:Ganoderma Lucidum Karst,又称林中灵、琼珍,是多孔菌科真菌灵芝的子实体。具有补气安神、止咳平喘的功效,用于眩晕不眠、心悸气短、神经衰弱、虚劳咳喘,延年益寿的功效。《本草经集注》曰:此六芝皆仙草之类,俗所稀见,族种甚多,形色环异,并载《芝草图》中。今俗所用紫芝,此是朽树木株上所生,状如木檽。《纲目》把历代有关芝类的记载加以引证,并提出了自己的见解,曰:芝类甚多,亦有花实者,本草惟以六芝标名,然其种属不可不识。《神农本草经》:“赤芝,味苦平。主胸中结,益心气,补中,增慧智,不忘。久食,轻身不老,延年神仙。一名丹芝。灵芝药用在我国已有2000多年的历史,被历代医药家视为滋补强壮、扶正固本的神奇珍品。药理研究证明,灵芝有多方面的生物活性。主含氨基酸、多肽、蛋白质、真菌溶菌酶(fungal lysozyme),以及糖类(还原糖和多糖)、麦角甾醇、三萜类、香豆精甙、挥发油、硬脂酸、苯甲酸、生物碱、维生素B2及C等;孢子还含甘露醇、海藻糖(trehalose)。灵芝对中枢神经***、心血管***、呼吸***、内分泌功能、保肝、抗氧化、延缓衰老、抗炎作用,抗肿瘤等都起到很好的治疗作用,尤其是灵芝提取物在体外具有明显的抗肿瘤作用,保护放化疗损伤,免疫调节,并对放射线和化疗药引起的正常人细胞的损伤具有保护作用。
人参,拉丁学名Panax ginseng C. A. Mey. 别称 圆参、黄参、棒槌、人衔、鬼盖、神草、土精、地精、海腴、人葠,为多年生草本植物,喜阴凉,叶片无气孔和栅栏组织,无法保留水分,温度高于32度叶片会灼伤,郁闭度0.7-0.8。通常3年开花,5-6年结果,花期5-6月,果期6-9月。生长于北纬33度-48度之间的海拔数百米的以红松为主的针阔混交林或落叶阔叶林下,产于中国东北、朝鲜、韩国、日本、俄罗斯东部。人参是闻名遐迩的“东北三宝”之一。性味:味甘、微苦,性温、平。归脾、肺经、心经。补气,固脱,生津,安神,益智。功效:大补元气,复脉固脱,补脾益肺,生津,安神。主治:体虚欲脱,肢冷脉微,脾虚食少,肺虚喘咳,津伤口渴,内热消渴,久病虚羸,惊悸失眠,阳痿宫冷;心力衰竭,心原性休克。用于气短喘促,心悸健忘,口渴多汗,食少无力,一切急慢性疾病及失血后引起的休克、虚脱。大补元气,固脱生津,安神。治劳伤虚损,食少,倦怠,反胃吐食,大便滑泄,虚咳喘促,自汗暴脱,惊悸,健忘,眩晕头痛,阳痿,尿频,消渴,妇女崩漏,小儿慢惊,及久虚不复,一切气血津液不足之证。
银杏叶,拉丁学名:Ginkgobiloba,别称:飞蛾叶、鸭脚子,二名法 Ginkgobiloba为银杏科植物银杏Ginkgo biloba L的干燥叶。秋季叶尚绿时采收,及时干燥。是广西的野生植物。其他地方一般为人工栽培。具有活血化瘀,通络止痛,敛肺平喘,化浊降脂的功效。用于瘀血阻络,胸痹心痛,中风偏瘫,肺虚咳喘,高脂血症。性味,甘、苦、涩,平。归经,归心、肺经。有活血化瘀,通络止痛,敛肺平喘,化浊降脂,抗癌等作用。用于瘀血阻络,胸痹心痛,中风偏瘫,肺虚咳喘,高脂血症。
石斛,石斛(Dendrobium candidum wall.ex Lindl.)为兰科(Orchidaeae)石斛,属(Dendrobium) 多年生草本植物,铁皮石斛是《 中华人民共和国药典》记载的一种极为珍稀名贵的中药材,石斛性味甘、微寒,入胃、肾经入胃、肺,肾经,生津益胃,清热养阴,润肺止咳, 益肾明目。历代药学经典对石斛的药效记载有,《 本草纲目》将石斛列为药用,《神农本草经》指出石斛具有生津、止渴、镇痛、消除水肿之功效,主治热病阴虚、目暗、胃弱、声音嘶哑等疾病,对声带疲劳、声音嘶哑,恢复其美音有特殊疗效。中国有句古话叫做“北有人参,南有枫斗”。石斛是我国名贵中药,素有“中华仙草”、“药中黄金”之美称,列“中华九大仙草”之首,被国际药用植物界称为“药界大熊猫”。具有免疫调节、延缓衰老等功效。不仅是大家熟悉的“脉络宁注射液”的必需原料,还是数十种中成药及保健品的必要原料。
淫羊藿,学名:Epimedium brevicornu Maxim.,别称:短角淫羊藿,又称仙灵脾。多年生草本植物,植株高20-60厘米,根状茎粗短,暗棕褐色,二回三出复叶基生和茎生,具长柄,小叶纸质或厚纸质,叶缘具刺齿,花白色或淡黄色,花期5-6月,果期6-8月。李时珍曰:淫羊藿味甘气香,性温不寒,能益精气,真阳不足宜之。主要价值淫羊藿味辛甘性温,走肝肾二经。为补命门、益精气、强筋骨、补肾壮阳之要药,有补肾壮阳,祛风除湿。治阳痿不举,小便淋沥,筋骨挛急,半身不遂,腰膝无力,风湿痹痛,四肢不仁作用。临床常用于治疗男子阳痿不举、滑精早泄、小便不禁以及女子***等症。现代研究表明,淫羊藿含淫羊藿甙、挥发油、蜡醇、植物甾醇、鞣质、维生素E等成分。能兴奋性机能,对动物有促进***分泌作用。还有降压(引起周围血管舒张)、降血糖、利尿、镇咳祛痰以及维生素E样作用。药理实验研究表明,淫羊藿能增加心脑血管血流量,促进造血功能、免疫功能及骨代谢,具有抗衰老、抗肿瘤等功效。近代医学专家研究发现,淫羊藿能有效杀死乳腺癌细胞。
地龙,别名:蚯蚓,外文名:rainworm,最早的中药学专著《神农本草经》中收载的67种动物药中就有蚯蚓,具有清热定惊、通络、平喘、利尿的功效。常炒制后用于高热、神昏、惊痫抽搐、关节痹痛、肺热喘咳、尿少水肿、高血压等症。主含多种氨基酸。李时珍在《本草纲目》称之为具有通经活络、活血化瘀、预防治疗心脑血管疾病作用,地龙具有利尿、镇痛、平喘、降压、解热、抗惊厥等作用。地龙含有地龙素、地龙解热素、维生素B族复合体等成分。地龙可以提取蛋白酶、蚓激酶、蚯蚓纤溶酶等生物药品。药用功能一是具有清热息风,用于高热惊痫、癫狂。地龙咸寒降泄,性走窜,既能息风止痉,又善清解高热,故适用于高热所致的狂躁,惊风抽搐,癫痫等症;二是通经活络,用于痹证及半身不遂。地龙长于通行经络,用于多种原因引起的经络阻滞,血脉不畅,肢节不利之证。因其性寒能清热,故适宜治疗关节红肿疼痛、屈伸不利之热痹,亦用治风寒湿痹,肢体关节麻木、疼痛、屈伸不利等症,治疗气虚血滞,中风后经络不利、半身不遂、口眼歪斜等症;三是清肺平喘,用于肺热哮喘。清肺热平喘。用治邪热壅肺,肺失肃降之喘息不止,喉中哮鸣有声者;四是清热利尿,用于热结膀胱,小便不利或尿闭不通。
艾草,学名:Artemisia argyi H.Lév. & Vaniot,别名:萧茅、冰台、遏草、香艾、蕲艾、艾萧、艾蒿、艾蒿、蓬藁、艾﹑灸草﹑医草﹑黄草﹑艾绒等。多年生草本或略成半灌木状,植株有浓烈香气。茎单生或少数,褐色或灰黄褐色,基部稍木质化,上部萆质,并有少数短的分枝,叶厚纸质,上面被灰白色短柔毛,基部通常无假托叶或极小的假托叶,上部叶与苞片叶羽状半裂、头状花序椭圆形,花冠管状或高脚杯状,外面有腺点,花药狭线形,花柱与花冠近等长或略长于花冠。瘦果长卵形或长圆形。花果期9-10月。全草入药,性温、苦、辛、温,微甘,无毒,入脾、肝、肾。有温经、去湿、散寒、止血、消炎、平喘、止咳、安胎、抗过敏等作用。艾草有散寒除湿,纯阳之性、通十二经、具回阳、理气血、逐湿寒、调经止血﹑安胎止崩等功效。治***、经痛腹痛﹑流产﹑子宫出血,根治风湿性关节炎﹑头风﹑月内风等。艾叶晒干捣碎得“艾绒”,制艾条供艾灸用,又可作“印泥”的原料,或制药枕头、药背心,防治老年慢性支气管炎或哮喘及虚寒胃痛等;此外全草作杀虫的农药或薰烟作房间消毒、杀虫药。嫩芽及幼苗作菜蔬。亦常用于针灸。因它可削冰令圆,又可炙百病,为医家最常用之药。现代实验研究证明,艾叶具有抗菌及抗病毒作用;平喘、镇咳及祛痰作用;止血及抗凝血作用;镇静及抗过敏作用;护肝利胆作用等。艾草可作“艾叶茶”、“艾叶汤”、“艾叶粥”等食谱,以增强人体对疾病的抵抗能力。艾草具有一种特殊的香味,这特殊的香味具有驱蚊虫的功效,所以,古人常在门前挂艾草,一来用于避邪,二来用于赶走蚊虫。
一点红,别称:羊蹄草、千日红、假芥兰、叶下红,植物界,被子植物门,双子叶植物纲,桔梗目,菊科,一年生或多年生草本,根茎细长,圆柱形,浅棕黄色;茎少分枝,细圆柱形,有纵纹,灰青色,基部叶卵形、琴形,上部叶较小,基部稍抱茎;纸质。头状花序干枯,花多已脱,花托及总苞残存,苞片茶褐色,膜质。瘦果浅黄褐色,冠毛极多,白色。常生于村旁、路边、田园和旷野草丛中,全年均可采,洗净,鲜用或晒干。其味苦,性凉。有清热解毒,散瘀消肿之功效。用于上呼吸道感染,口腔溃疡,肺炎,乳腺炎,肠炎,菌痢,***,疮疖痈肿,湿疹,跌打损伤。
旱连草,拉丁学名:Herba Ecliptae Eclipta prostrala L,别称:金陵草、莲子草,一年生草本,全株被白色粉毛,折断后流出的汁液数分钟后即呈蓝黑色。茎直立或基部倾伏,着地生根,绿色或红褐色。叶对生;叶片线状椭圆形至披针形,全缘或稍有细齿,两面均被白色粉毛。头状花序腋生或顶生,总苞钟状,花托扁平,托上着生少数舌状花及多数管状花;舌状花雌性,花冠白色,发育或不发育;管状花两性,黄绿色,全发育。瘦果黄黑色,生于路边、湿地、沟边或田间。《唐本草》:“味甘酸,平,无毒。”《滇南本草》:“性寒,味咸。” 入肝、肾经。《本草经疏》:“入肾、肝。胃、大小肠。”《得配本草》:“入足少阴经血分。” 功能:滋补肝肾,乌须固齿,凉血止血。主治:肝肾不足,眩晕耳鸣,视物昏花,腰膝酸软,发白齿摇,劳淋带浊,咯血,吐血,衄血,尿血,血痢,崩漏,外伤出血。用法:服:煎汤熬膏、捣汁或入丸、散。外用:捣敷、研末撒或捣绒塞鼻。性味归经:甘酸,凉。旱莲草含有皂甙、挥发油、鞣质、维生素A、旱莲草素等成分对对金黄色葡萄球菌、伤寒秆菌、宋氏痢疾杆菌、绿脓杆菌有抑菌作用;墨早莲的苯、丙酮、石油醚和50%乙醇提取物对四氯化碳造成的肝损伤均有保护作用,显示墨早莲的乙醇提取物对肝功能有明显保护作用;墨旱莲煎剂能明显增强非特异性免疫和细胞免疫功能,对体液免疫似无影响;墨旱莲水溶性提取物,对染色体损伤有一定保护作用,墨旱莲的这种抗诱变作用和增强机体免疫功能是其补肾延衰的部分药理基础;墨旱莲浸膏临床试用于冠心病,心绞痛病例有—定疗效相符;用墨早莲叶粉敷于出血处,并稍加压迫,有良好的止血效果,水提物亦有显著止血作用;另外墨早莲煎剂对食管癌109细胞有中等程度的杀伤作用。
白菊花,拉丁文名:White Chrysanthemum,又名甘菊、杭菊、杭白菊、茶菊、药菊。白菊花内含菊甙、氨基酸、黄酮类及多种维生素和微量元素,中华医学研究表明,白菊具有养肝明目、清心、补肾、健脾和胃、润喉、生津以及调整血脂等功效。分布于河南、安徽和浙江。性味:辛、甘、苦,微寒。归经:归肺、肝经。功效:效疏散风热,平肝明目,清热解毒。主治:风热感冒,发热头痛,目赤昏花,肝肾不足,目暗昏花,眩晕惊风,治肝阳上亢,头痛眩晕,善疏风清热,清肝泻火,兼能益阴明目,故可用治肝经风热,或肝火上攻所致目赤肿痛,疏风清肝明目之效;清热解毒,尤善解疔毒,故可用治疔疮肿毒。白菊花茶能“主诸风头眩、肿痛、目欲脱、皮肤死肌、恶风湿痹,久服利气,菊花体轻达表,气清上浮,微寒清热,长於疏散风热,故常用於治风热感冒,或温病初起,温邪犯肺、发热、头痛、咳嗽等症,常与桑叶、连翘、薄荷、桔梗等同用,如桑菊饮。白菊花更是菊花的上品,其功善疏风清热,清肝泻火,兼能益阴明目,故可用治肝经风热、或肝火上攻所致目赤肿痛,可用于治疔疮肿毒。
决明子,别称:马蹄决明、钝叶决明、假绿豆、草决明。是豆科植物决明或小决明的干燥成熟种子,以其有明目之功而名之。秋季采收成熟果实,晒干,打下种子,除去杂质。决明子味苦、甘、咸,性微寒,入肝、肾、大肠经;润肠通便,降脂明目,治疗便秘及高血脂,高血压。清肝明目,利水通便,有缓泻作用,降血压降血脂。无毒,性味味甘、苦,性寒,微咸。归经归肝、大肠经。功效:清肝明目,润肠通便。主治:用于目赤涩痛,羞明多泪,头痛眩晕,目暗不明,大便秘结,《本草纲目》:“除肝胆风热,淫肤白膜,青盲。”《中华本草》述其应用较为广泛,载曰:“清肝益肾,明目,利水通便。主治目赤肿痛,羞明泪多、青盲、雀目、头痛头晕、视物昏暗、肝硬化腹水、小便不利,习惯性便秘。外治肿毒、癣疾。”《本草求真》:“决明子,除风散热。凡人目泪不收,眼痛不止,多属风热内淫,以致血不上行,治当即为驱逐;按此苦能泄热,咸能软坚,甘能补血,力薄气浮,又能升散风邪,故为治目收泪止痛要药。并可作枕以治头风,但此服之太过,搜风至甚,反招风害,故必合以蒺藜、甘菊、枸杞、生地、女贞实、槐实、谷精草相为补助,则功更胜。谓之决明,即是此意。”《本草正义》:“决明子明目,乃滋益肝肾,以镇潜补阴为义,是培本之正治,非如温辛散风,寒凉降热之止为标病立法者可比,最为有利无弊。
玉米须,别称:玉蜀黍须、蜀黍须、包谷须。为禾本科植物玉蜀黍Zea mays L.的花柱和柱头。夏、秋果实成孰时收集,除去杂质。鲜用或晒干生用。淡绿色、黄绿色至棕红色,有光泽,略透明,气无,味淡。以柔软、有光泽者为佳。《滇南本草》:宽肠下气。治妇人乳结,乳汁不通,红肿疼痛,怕冷发热,头痛体困;《岭南采药录》:和猪肉煎汤治糖尿病。又治小便淋沥砂石,苦痛不可忍,煎汤频服;《民间常用草药汇编》:能降低血压,利尿消肿。治鼻血、红崩;《四川中药志》:清血热,利小便。治黄疸,风热,出疹,吐血及红崩。性味:味甘、淡,性平。归经:归膀胱、肝、胆经。功能:有利尿消肿以及清肝利胆的功效。主治:主水肿,小便淋沥,黄疸,胆囊炎,胆结石,高血压,糖尿病,乳汁不通。玉米须烧灰还可治风疹块和热毒。
连翘,拉丁学名:Forsythia suspensa,落叶灌木,是木樨科连翘属植物。连翘早春先叶开花,花开香气淡艳,满枝金黄,艳丽可爱,是早春优良观花灌木,株高可达3米,枝干丛生,小枝黄色,拱形下垂,中空。叶对生,单叶或三小叶,卵形或卵状椭圆形,缘具齿。花冠黄色,1-3朵生于叶腋;果卵球形、卵状椭圆形或长椭圆形,先端喙状渐尖,表面疏生皮孔,生于山坡灌丛、林下或草丛中,或山谷、山沟疏林中,海拔250-2200米。果实可以入药,性味:苦,凉。归经:入心、肝、胆经,功能主治:清热,解毒,散结,消肿。治温热,丹毒,斑疹,痈疡肿毒,瘰疬,小便淋闭。
风姜,外文名:RHIZOMA ALPINIAE OFFICINARUM 为姜科植物高良姜 Alpiniaofficinarum Hance的干燥根茎。夏末秋初采挖,除去须根及残留的鳞片,洗净,切段,晒干。制法:除去杂质,洗净,润透,切薄片,晒干。性状:本品呈圆柱形,多弯曲,有分枝,长5~9cm,直径1~1.5cm。表面棕红色至暗褐色,有细密的纵皱纹及灰棕色的波状环节,节间长0.2~1cm,一面有圆形的根痕。质坚韧,不易折断,断面灰,棕色或红棕色,纤维性,中柱约占1/3。气香,味辛辣、大温、无毒。风姜有温胃散寒,消食止痛,促进食欲之功效,用于治疗脘腹冷痛、胃寒呕吐嗳气吞酸、痢疾和胃肠炎等。具有温中止痛作用:风姜水提物和醚提物能显著对抗小鼠水浸应激型溃疡和大鼠盐酸损伤性溃疡;水提物对小鼠胃肠道推进有明显抑制,两种提取物都能显著对抗蓖麻油引起的腹泻,其水提物还对番泻叶引起的腹泻有效,水提物有协同转氨酶升高作用,两种提取物对麻醉大鼠均有明显利胆作用,醚提物作用较强。在热极法和乙酸扭体试验中,两种提取物都有明显镇痛作用。风姜对微循环的影响:风姜为芳香温痛类中药,对心绞痛具有快速止痛作用,对轻度使肾上腺素引起的微动脉血流停止或减慢有推迟作用。对管径收缩时间有推迟作用。在对给肾上腺素10分钟后使管径有恢复作用,还有对微动脉轻度收缩作用
紫苏,学名:Perilla frutescens (L.) Britt,别名:桂荏、白苏、赤苏等;为唇形科一年生草本植物。具有特异的芳香,叶片多皱缩卷曲,完整者展平后呈卵圆形,长4至11厘米,宽2.5至9厘米,先端长尖或急尖,基部圆形或宽楔形,边缘具圆锯齿,两面紫色或上面绿色,下表面有多数凹点状腺鳞,叶柄长2至5厘米,紫色或紫绿色,质脆。嫩枝紫绿色,断面中部有髓,气清香,味微辛。紫苏叶能散表寒,发汗力较强,用于风寒表症,见恶寒、发热、无汗等症;行气宽中,紫苏叶用于脾胃气滞、胸闷、呕恶。紫苏既能发汗散寒以解表邪,又能行气宽中、解郁止呕,故对风寒表症而兼见胸闷呕吐症状的;或无表症而有气滞不畅症状的,也可用于宣通。用于感冒风寒:用于胸闷、呕恶等症:紫苏用于脾胃气滞、胸闷、呕恶,壮族民间常用紫苏配以大蒜酸梅辣椒加香油调制去脂降低胆固醇,减肥。
茉莉花,拉丁学名 Jasminum sambac (L.) Ait,别称:茉莉、香魂、莫利花、没丽、没利、抹厉、末莉、末利、木梨花,别名:茉莉,木犀科、素馨属直立或攀援灌木,高达3米。小枝圆柱形或稍压扁状,有时中空,疏被柔毛。叶对生,单叶,叶片纸质,圆形、椭圆形、卵状椭圆形或倒卵形,两端圆或钝,基部有时微心形,在上面稍凹入或凹起,下面凸起,细脉在两面常明显,微凸起,除下面脉腋间常具簇毛外,其余无毛;裂片长圆形至近圆形,先端圆或钝。果球形,呈紫黑色。花期5-8月,果期7-9月。茉莉的花极香,为著名的花茶原料及重要的香精原料;茉莉花、叶和根均可药用,茉莉花:辛、甘,温。理气,开郁,辟秽,和中。用于下痢腹痛,目赤红肿,疮毒。茉莉花可提取茉莉花油,油中主要成分为苯甲醇及其酯类、茉莉花素、芳樟醇、安息香酸芳樟醇酯。根含生物碱、甾醇。动物实验表明茉莉根醇浸液可使小白鼠自发活动明显减少;可延长环已巴比妥纳所引起小白鼠的睡眠时间;可降低小白鼠被动活动的能力。营养成分:每100克茉莉花含挥发油性物质2-3克,主要成分为苯甲醇或其脂类、茉莉花素、芳樟醇、安息香酸芳樟醇酯等,还含有吼哚,素馨内酯等物质。茉莉花具有辛、甘、凉、清热解毒、利湿、安神、镇静作用,可治下痢腹痛、目赤肿痛、疮疡肿毒等病症,茉莉花以其浓郁的香气让人心旷神怡,受到人们的欢迎,茉莉花茶不但有凉血的作用,还具有多种医药保键功效,可去除胃部不适感,除了起到提神、养神之效。
与现在技术相比,本发明突出的实质性特点和显著的进步是:
1.结构简单,操作方便。本发明的颞颌关节恢复装置设有让患者感到柔软舒适的耳托面板和颞颌关节面板;下颌托板除了面料柔软垫以外,在柔软垫下底面还安装有底板,底板上设有至少弹簧组件,其中弹簧的大小是根据患者不同程度的病情而设计有不同的直径,让患者做颞颌关节恢复时增加一定的难度但又不至于太困难,在被患者被强迫运动的过程中,快速达到患者的恢复功能,大大加快了患者治愈疾病的速度,且固定的头带设能调节距离并实现分离或定位的旋钮齿轮齿条调节机构、魔术贴、齿状扣带、卡扣或磁性贴,可以适应大小不同的任何患者的使用。
2.治疗效果好。本发明药垫内放入了抗肿瘤以及消除化疗后的副作用的配方,本配方依据传统中医理论,使用最佳的配方,从人体的胃、肠、脾、肺以及肝入手,以消化***为主,进而调节人体微生态平衡与健康,增强身体免疫力以及防癌抗癌和组方,方中遵循“君、臣、佐、使”原则,主要由君药:以灵芝为主,配上产于广西野生的银杏叶,具有散瘀肿、清热解毒、除湿毒、通调三道两路之作用;臣药:人参、石斛、淫羊藿和连翘能解毒,滋阴清热,润肺益肾;辅药:加入地龙和风姜能活血化淤,加入一点红、旱连草、白菊花、决明子、玉米须等药物组成可用于血瘀毒盛,气阴已虚之肝癌等恶性肿瘤的辅助治疗。加入艾草、紫苏对脾胃进行调理,最后加入具有解郁止呕且香气茉莉花。方中灵芝对中枢神经***、心血管***、呼吸***、内分泌功能、保肝、抗氧化、延缓衰老、抗炎作用,抗肿瘤等都起到很好的治疗作用,尤其是灵芝提取物在体外具有明显的抗肿瘤作用,保护放化疗损伤,免疫调节,并对放射线和化疗药引起的正常人细胞的损伤具有保护作用;银杏叶有活血化瘀,通络止痛,敛肺平喘,化浊降脂。用于瘀血阻络,灵芝对中枢神经***、心血管***、呼吸***、内分泌功能、保肝、抗氧化、延缓衰老、抗炎作用,抗肿瘤等都起到很好的治疗作用;石斛具有生津养胃、止渴、镇痛以及消除水肿之功效,主治热病阴虚、目暗、胃弱、声音嘶哑等疾病,用于阴伤津亏,口干烦渴,食少干呕,病后虚热,目暗不明,益胃养阴止痛,促进腺体分泌和脏器运动,也具有滋阴清热、润肺益肾、明目强腰的功能,还具有降血糖作用,增强机体免疫力,延缓衰老等功效;人参有大补元气,复脉固脱,补脾益肺,生津,安神,主治体虚欲脱,肢冷脉微,脾虚食少,肺虚喘咳,津伤口渴,内热消渴,久病虚羸,惊悸失眠;淫羊藿调气、解毒、补虚和通调三道两路之作用。对于血瘀毒盛,气阴已虚之肝癌等恶性肿瘤的辅助治疗,具有较好的临床效果;地龙具有通经活络、活血化瘀、预防治疗心脑血管疾病作用;连翘主治清热,解毒,散结,消肿。治温热,丹毒,斑疹,痈疡肿毒,瘰疬,小便淋闭等;一点红有清热解毒,散瘀消肿之功效;旱连草显示墨早莲的乙醇提取物对肝功能有明显保护作用;墨旱莲煎剂能明显增强非特异性免疫和细胞免疫功能,墨早莲煎剂对食管癌109细胞有中等程度的杀伤作用;白菊花具有疏风清热,清肝泻火,兼能益阴明目之功效;决明子清肝明目,利水通便,又能升散风邪;玉米须有利尿消肿以及清肝利胆的功效;风姜有温胃散寒,消食止痛,促进食欲之功效;艾草有散寒除湿,纯阳之性、通十二经、具回阳、理气血、逐湿寒、有抗菌及抗病毒作用,能增强人体对疾病的抵抗能力;紫苏用于脾胃气滞、胸闷、呕恶。紫苏既能发汗散寒以解表邪,又能行气宽中、解郁止呕;茉莉花可治下痢腹痛、目赤肿痛、疮疡肿毒等病症,且有浓郁的香气,使得患者心情愉悦。
本发明的颞颌关节恢复装置,通过将放置于患者脸部的两颞颌关节外放入中草药药垫,配合下颌托板的弹簧,让患者做颞颌关节恢复时增加一定的难度,在被患者被强迫运动的过程中,药垫内药物慢慢渗入患者的体内,起到治疗的作用,本药垫的抗肿瘤的配方,具有传统壮族特色,药物处方来源于壮族民间临床经验方。中草药治疗恶性肿瘤,是整体治疗与辨证施治相结合,也就是整体与局部相结合、既看到机体对病邪的抵御能力,又看到局部病变对机体的影响,在辨病与辨证的基础上,通过一些针对性强的特殊药物的配伍组方,恰到好处地进入机体,调节气血、阴阳、津液的平衡。药物分子经过物理反应和化学反应进入全身,有的吸附在细胞的表面、腐蚀围杀癌细胞,灵芝、银杏叶和人参具有散瘀肿、清热解毒,补充体能,配以石斛、淫羊藿、连翘解毒、补虚,滋阴清热、润肺益肾,地龙和风姜通经活络、活血化瘀、散寒除湿,消食止痛,一点红、旱连草、白菊花、决明子和玉米须疏风清热,清肝泻火,清肝明目,有利尿消肿,艾草、紫苏和茉莉花行气宽中、解郁止呕,尤其是灵芝提取物在体外具有明显的抗肿瘤作用,保护放化疗损伤,免疫调节,并对放射线和化疗药引起的正常人细胞的损伤具有保护作用,通过制剂学、药效学、毒理学和质量控制等方面的深入研究,各种制剂安全、有效、质量稳定、可控。
附图说明
图1是本发明实施例1的主视结构示意简图。
图2是图1的左视结构示意简图。
图3是图1的立体结构示意简图。
图4是图1的展开的结构示意简图。
图5是图4的A-A剖视结构示意简图。
图6是头带的连接装置5为齿轮结构连接示意简图。
图7是头带的连接装置5为卡扣结构连接示意简图。
图8是本发明的使用状态侧面结构示意简图。
图9是本发明的使用状态正面结构示意简图。
图10是本发明的实施例2的使用状态侧面结构示意简图。
图中部件名称及序号:
头带1、耳托面板2、颞颌关节面板3、下颌托板4、连接装置5、面料6、柔软垫7、药垫8、底板9、弹簧组件10、支撑托架11。
具体实施方式
以下结合附图及其实施例描述本发明的结构。
参看附图1~10所示,本发明的颞颌关节恢复装置,通过以下方案实现:
实施例1
本颞颌关节恢复装置,包括头带1、耳托面板2、颞颌关节面板3和下颌托板4,所述头带1、耳托面板2和颞颌关节面板3均为左右对称两个,所述耳托面板2的一端与头带1连接,另一端与颞颌关节面板3的上部,所述左右颞颌关节面板3的下部均与下颌托板4紧固连接,所述头带1的左右末端还设有连接装置5。所述的耳托面板2包括面料6以及设于面料6内部的柔软垫7;所述的颞颌关节面板3包括面料6以及设于面料6内部的药垫8;所述的下颌托板4包括面料6以及设于面料6内部的柔软垫7,在所述柔软垫7下底面还安装有底板9,在所述底板9上设有三个弹簧组件10,所述的弹簧组件10,其中弹簧的直径是0.2mm;所述的连接装置5的结构为能调节距离并实现分离或定位的旋钮齿轮齿条调节机构、魔术贴、齿状扣带、卡扣、磁性贴中的任意一种。
以上所述的药垫8,其配方按重量比分为:灵芝10-16,人参2-5、银杏叶3-6、石斛5-10、淫羊藿6-12、连翘6-10、地龙3-8、艾草8-12、风姜6-8、一点红10-15、旱连草8-10、白菊花6-10、决明子5-8、玉米须12-15、紫苏8-10、茉莉花10-20。
以上所述的药垫8,其制作方法是将所述配方的新鲜生草洗净打碎直接制成的药垫。
实施例2
本颞颌关节恢复装置,包括头带1、耳托面板2、颞颌关节面板3和下颌托板4,所述头带1、耳托面板2和颞颌关节面板3均为左右对称两个,所述耳托面板2的一端与头带1连接,另一端与颞颌关节面板3的上部,所述左右颞颌关节面板3的下部均与下颌托板4紧固连接,所述头带1的左右末端还设有连接装置5。所述的耳托面板2包括面料6以及设于面料6内部的柔软垫7;所述的颞颌关节面板3包括面料6以及设于面料6内部的药垫8;所述的下颌托板4包括面料6以及设于面料6内部的柔软垫7,在所述柔软垫7下底面还安装有底板9,在所述底板9上设有2个弹簧组件10,所述的弹簧组件10,其中弹簧的直径是2mm;所述的下颌托板4的底部还设有支撑托架11,用于方便双手托住或架于桌面上,所述支撑托架11的长短是固定式或是伸缩式结构;所述的连接装置5的结构为能调节距离并实现分离或定位的旋钮齿轮齿条调节机构、魔术贴、齿状扣带、卡扣、磁性贴中的任意一种。
以上所述的药垫8,其配方按重量比分为:灵芝10-16,人参2-5、银杏叶3-6、石斛5-10、淫羊藿6-12、连翘6-10、地龙3-8、艾草8-12、风姜6-8、一点红10-15、旱连草8-10、白菊花6-10、决明子5-8、玉米须12-15、紫苏8-10、茉莉花10-20。
以上所述药垫8,其制作方法是将所述配方洗净晒干打碎成粉状制成的药垫。
临床观察:
本发明颞颌关节恢复装置的使用案例:
1.鼻咽癌,李x、男、56岁,广西南宁市人。于2015年3月,检查为鼻咽癌,到医院放疗治疗,情绪低落,口干舌燥,颞颌关节麻木,不思饮食。放疗后经使用本发明的颞颌关节恢复装置2个月后,各症状消失,坚持使用半年,颞颌关节麻木消失,饮食正常,面色红润。
2.食道癌,韦x、女,62岁,广西南宁市青秀区人,食道癌采用药物加放疗治疗,出现四肢不温,手足浮肿,汗出不止,口腔麻木,说话不清。后使用本发明的颞颌关节恢复装置3个月后,且配合药垫8辅助治疗,四肢不温、汗出不止症状消失,继续坚持使用1年,各症状消失。
3.鼻咽癌,农x,男,42岁,广西南宁市江西乡人。自觉鼻塞、鼻涕中带血,耳闷堵感,头痛,听力下降,经医院检查为鼻咽癌。于2017年3月到广西303医院就诊药物结合加放疗治疗,治疗后感觉颞颌关节麻木,不思饮食,恶心呕吐,使用本发明的颞颌关节恢复装置3个月后,各症状消失,能正常工作。
Claims (10)
1.一种颞颌关节恢复装置,其特征在于:包括头带(1)、耳托面板(2)、颞颌关节面板(3)和下颌托板(4),所述头带(1)、耳托面板(2)和颞颌关节面板(3)均为左右对称两个,所述耳托面板(2)的一端与头带(1)连接,另一端与颞颌关节面板(3)的上部,所述左右颞颌关节面板(3)的下部均与下颌托板(4)紧固连接,所述头带(1)的左右末端还设有连接装置(5)。
2.根据权利要求1所述的颞颌关节恢复装置,其特征在于:所述的耳托面板(2)包括面料(6)以及设于面料(6)内部的柔软垫(7)。
3.根据权利要求1所述的颞颌关节恢复装置,其特征在于:所述的颞颌关节面板(3)包括面料(6)以及设于面料(6)内部的药垫(8)。
4.根据权利要求1所述的颞颌关节恢复装置,其特征在于:所述的下颌托板(4)包括面料(6)以及设于面料(6)内部的柔软垫(7),在所述柔软垫(7)下底面还安装有底板(9),在所述底板(9)上设有至少(2)个弹簧组件(10)。
5.根据权利要求1所述的颞颌关节恢复装置,其特征在于:所述的连接装置(5)的结构为能调节距离并实现分离或定位的旋钮齿轮齿条调节机构、魔术贴、齿状扣带、卡扣、磁性贴中的任意一种。
6.根据权利要求3所述的颞颌关节恢复装置,其特征在于:所述的药垫(8),其配方按重量比分为:灵芝10-16,人参2-5、银杏叶3-6、石斛5-10、淫羊藿6-12、连翘6-10、地龙3-8、艾草8-12、风姜6-8、一点红10-15、旱连草8-10、白菊花6-10、决明子5-8、玉米须12-15、紫苏8-10、茉莉花10-20。
7.根据权利要求5所述的颞颌关节恢复装置,其特征在于:所述的药垫(8),其制作方法是将所述配方的新鲜生草洗净打碎直接制成的药垫。
8.根据权利要求5所述的颞颌关节恢复装置,其特征在于:所述的药垫(8),其制作方法是将所述配方洗净晒干打碎成粉状制成的药垫。
9.根据权利要求4所述的颞颌关节恢复装置,其特征在于:所述的弹簧组件(10),其中弹簧的直径是0.2~2mm。
10.根据权利要求4所述的颞颌关节恢复装置,其特征在于:所述的下颌托板(4)的底部还设有支撑托架(11),所述支撑托架(11)的长短是固定式或是伸缩式结构。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711060612.XA CN107595459A (zh) | 2017-11-02 | 2017-11-02 | 颞颌关节恢复装置 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711060612.XA CN107595459A (zh) | 2017-11-02 | 2017-11-02 | 颞颌关节恢复装置 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107595459A true CN107595459A (zh) | 2018-01-19 |
Family
ID=61085235
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711060612.XA Pending CN107595459A (zh) | 2017-11-02 | 2017-11-02 | 颞颌关节恢复装置 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107595459A (zh) |
Citations (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3497217A (en) * | 1966-08-29 | 1970-02-24 | Jack Vincent Feather | Spring type neck and facial exerciser |
CN87208622U (zh) * | 1987-06-02 | 1988-03-02 | 郭建生 | 运动性颈托器 |
US5029577A (en) * | 1989-10-02 | 1991-07-09 | Jeff Sarkozi | Self adjusting, soft neck support collar |
JPH07313539A (ja) * | 1994-05-27 | 1995-12-05 | Toru Arimura | 頸椎装具 |
US5501646A (en) * | 1994-08-26 | 1996-03-26 | W. G. Miller Associates | Jaw, face and neck muscle exercise apparatus |
US5507718A (en) * | 1994-11-10 | 1996-04-16 | Kabat; Herman | Method and apparatus for applying neck traction |
CN1217222A (zh) * | 1997-11-12 | 1999-05-26 | 菲利普·J·泰恩 | 下巴和颈部锻炼器 |
CN1390594A (zh) * | 2002-07-30 | 2003-01-15 | 成都国嘉药物研究所 | 改善血液循环的混合物 |
CN100998773A (zh) * | 2007-01-07 | 2007-07-18 | 蔡绪旺 | 一种延年益寿、抗衰老的中药保健制剂 |
CN200963216Y (zh) * | 2006-08-07 | 2007-10-24 | 阎俊新 | 颞颌关节前脱位复位固定器 |
CN201079464Y (zh) * | 2007-07-20 | 2008-07-02 | 刘大力 | 下颌关节脱位复位固定帽 |
CN101305948A (zh) * | 2008-07-14 | 2008-11-19 | 北京航空航天大学 | 融合功能训练器的头部固定装置 |
CN102940781A (zh) * | 2012-11-20 | 2013-02-27 | 张经超 | 一种抗衰、理通中药组合物 |
CN103566331A (zh) * | 2012-07-29 | 2014-02-12 | 马野 | 一种艾癌康胶囊+纳米活性炭配血注剂 |
CN103566254A (zh) * | 2013-10-24 | 2014-02-12 | 宋海平 | 用于治疗急性放射性肺炎的中药组合物 |
CN103623205A (zh) * | 2012-08-30 | 2014-03-12 | 张艺琳 | 一种抗衰老中药及其制备方法 |
CN203468818U (zh) * | 2013-09-06 | 2014-03-12 | 周福亭 | 下颌骨固定装置 |
CN203506942U (zh) * | 2013-10-30 | 2014-04-02 | 哈励逊国际和平医院 | 气囊式颌骨骨折复位器 |
CN103976809A (zh) * | 2014-04-28 | 2014-08-13 | 河南科技大学第一附属医院 | 一种下颌骨脱位复位带 |
CN203852458U (zh) * | 2014-04-28 | 2014-10-01 | 河南科技大学第一附属医院 | 一种下颌骨脱位复位带 |
CN204207915U (zh) * | 2014-07-22 | 2015-03-18 | 中国人民解放军***武汉总医院 | 一种术后用颞下颌关节固定装置 |
CN204319012U (zh) * | 2014-12-09 | 2015-05-13 | 云南省玉溪市人民医院 | 下颌固定带 |
CN204411057U (zh) * | 2015-01-21 | 2015-06-24 | 胡明涛 | 一种颞下颌关节急性脱位复位后固定带 |
CN104825855A (zh) * | 2015-03-31 | 2015-08-12 | 陈琳 | 一种抗衰老中药组合物及制备方法 |
CN105105906A (zh) * | 2015-09-22 | 2015-12-02 | 谭玉莲 | 颌面部术后头颌部弹力套 |
KR20150142449A (ko) * | 2014-06-12 | 2015-12-22 | (주)새롬현대 | 수면중 코호흡을 유도하기 위한 입벌림 방지구 |
CN205181558U (zh) * | 2015-11-30 | 2016-04-27 | 中国人民解放军第四军医大学 | 一种下颌复位固定带 |
JP2016086973A (ja) * | 2014-10-31 | 2016-05-23 | 学校法人愛知学院 | 顎関節脱臼防止具 |
CN105727156A (zh) * | 2014-12-10 | 2016-07-06 | 王令喜 | 抑癌解疼巴布膏及制备方法 |
CN105832498A (zh) * | 2016-06-13 | 2016-08-10 | 华北理工大学 | 下颌康复机器人 |
CN105982807A (zh) * | 2015-02-12 | 2016-10-05 | 王海英 | 一种下颌运动训练器 |
JP6083836B1 (ja) * | 2015-11-18 | 2017-02-22 | Ikk株式会社 | 顎固定用ベルト |
CN106492141A (zh) * | 2017-01-05 | 2017-03-15 | 熊瑞阳 | 一种中药组合物及其制备方法 |
CN106729432A (zh) * | 2017-01-19 | 2017-05-31 | 贾庭山 | 一种用于治疗心脑血管疾病的中药组合物 |
CN208096853U (zh) * | 2017-11-02 | 2018-11-16 | 赵书学 | 颞颌关节恢复装置 |
-
2017
- 2017-11-02 CN CN201711060612.XA patent/CN107595459A/zh active Pending
Patent Citations (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3497217A (en) * | 1966-08-29 | 1970-02-24 | Jack Vincent Feather | Spring type neck and facial exerciser |
CN87208622U (zh) * | 1987-06-02 | 1988-03-02 | 郭建生 | 运动性颈托器 |
US5029577A (en) * | 1989-10-02 | 1991-07-09 | Jeff Sarkozi | Self adjusting, soft neck support collar |
JPH07313539A (ja) * | 1994-05-27 | 1995-12-05 | Toru Arimura | 頸椎装具 |
US5501646A (en) * | 1994-08-26 | 1996-03-26 | W. G. Miller Associates | Jaw, face and neck muscle exercise apparatus |
US5507718A (en) * | 1994-11-10 | 1996-04-16 | Kabat; Herman | Method and apparatus for applying neck traction |
CN1217222A (zh) * | 1997-11-12 | 1999-05-26 | 菲利普·J·泰恩 | 下巴和颈部锻炼器 |
CN1390594A (zh) * | 2002-07-30 | 2003-01-15 | 成都国嘉药物研究所 | 改善血液循环的混合物 |
CN200963216Y (zh) * | 2006-08-07 | 2007-10-24 | 阎俊新 | 颞颌关节前脱位复位固定器 |
CN100998773A (zh) * | 2007-01-07 | 2007-07-18 | 蔡绪旺 | 一种延年益寿、抗衰老的中药保健制剂 |
CN201079464Y (zh) * | 2007-07-20 | 2008-07-02 | 刘大力 | 下颌关节脱位复位固定帽 |
CN101305948A (zh) * | 2008-07-14 | 2008-11-19 | 北京航空航天大学 | 融合功能训练器的头部固定装置 |
CN103566331A (zh) * | 2012-07-29 | 2014-02-12 | 马野 | 一种艾癌康胶囊+纳米活性炭配血注剂 |
CN103623205A (zh) * | 2012-08-30 | 2014-03-12 | 张艺琳 | 一种抗衰老中药及其制备方法 |
CN102940781A (zh) * | 2012-11-20 | 2013-02-27 | 张经超 | 一种抗衰、理通中药组合物 |
CN203468818U (zh) * | 2013-09-06 | 2014-03-12 | 周福亭 | 下颌骨固定装置 |
CN103566254A (zh) * | 2013-10-24 | 2014-02-12 | 宋海平 | 用于治疗急性放射性肺炎的中药组合物 |
CN203506942U (zh) * | 2013-10-30 | 2014-04-02 | 哈励逊国际和平医院 | 气囊式颌骨骨折复位器 |
CN103976809A (zh) * | 2014-04-28 | 2014-08-13 | 河南科技大学第一附属医院 | 一种下颌骨脱位复位带 |
CN203852458U (zh) * | 2014-04-28 | 2014-10-01 | 河南科技大学第一附属医院 | 一种下颌骨脱位复位带 |
KR20150142449A (ko) * | 2014-06-12 | 2015-12-22 | (주)새롬현대 | 수면중 코호흡을 유도하기 위한 입벌림 방지구 |
CN204207915U (zh) * | 2014-07-22 | 2015-03-18 | 中国人民解放军***武汉总医院 | 一种术后用颞下颌关节固定装置 |
JP2016086973A (ja) * | 2014-10-31 | 2016-05-23 | 学校法人愛知学院 | 顎関節脱臼防止具 |
CN204319012U (zh) * | 2014-12-09 | 2015-05-13 | 云南省玉溪市人民医院 | 下颌固定带 |
CN105727156A (zh) * | 2014-12-10 | 2016-07-06 | 王令喜 | 抑癌解疼巴布膏及制备方法 |
CN204411057U (zh) * | 2015-01-21 | 2015-06-24 | 胡明涛 | 一种颞下颌关节急性脱位复位后固定带 |
CN105982807A (zh) * | 2015-02-12 | 2016-10-05 | 王海英 | 一种下颌运动训练器 |
CN104825855A (zh) * | 2015-03-31 | 2015-08-12 | 陈琳 | 一种抗衰老中药组合物及制备方法 |
CN105105906A (zh) * | 2015-09-22 | 2015-12-02 | 谭玉莲 | 颌面部术后头颌部弹力套 |
JP6083836B1 (ja) * | 2015-11-18 | 2017-02-22 | Ikk株式会社 | 顎固定用ベルト |
CN205181558U (zh) * | 2015-11-30 | 2016-04-27 | 中国人民解放军第四军医大学 | 一种下颌复位固定带 |
CN105832498A (zh) * | 2016-06-13 | 2016-08-10 | 华北理工大学 | 下颌康复机器人 |
CN106492141A (zh) * | 2017-01-05 | 2017-03-15 | 熊瑞阳 | 一种中药组合物及其制备方法 |
CN106729432A (zh) * | 2017-01-19 | 2017-05-31 | 贾庭山 | 一种用于治疗心脑血管疾病的中药组合物 |
CN208096853U (zh) * | 2017-11-02 | 2018-11-16 | 赵书学 | 颞颌关节恢复装置 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101176590B1 (ko) | 숙취 해소용 한약 조성물 및 이를 함유하는 음료 | |
JP5864252B2 (ja) | 炮製を活用した薬用植物抽出物及びこれを含有する皮膚外用剤組成物 | |
CN102048933B (zh) | 一种治疗小儿腹泻的中药组合物及其制备方法 | |
CN102988638B (zh) | 一种青钱柳叶降脂降糖保健茶及其制备方法 | |
CN107156828A (zh) | 一种适用于炎性肠病患者的全营养配方食品 | |
CN106962921A (zh) | 一种健康饮食添加粉及其制备方法 | |
CN107156829A (zh) | 一种适用于肝病患者的全营养配方食品 | |
CN104857271B (zh) | 增强机体免疫力中药饮片组合制剂、制备方法及组合包装 | |
CN103417886B (zh) | 一种治疗支气管哮喘的中药组合物及其制备方法 | |
CN109350657A (zh) | 一种治疗风湿病的组合物、制备方法及其应用 | |
CN104707004A (zh) | 降血压的药物 | |
CN107595459A (zh) | 颞颌关节恢复装置 | |
CN105617268A (zh) | 一种治疗鳞屑角化型脚气的药物 | |
CN104324229A (zh) | 缓解疲劳的组合物及其制剂和应用 | |
CN109223867A (zh) | 止咳化痰平喘的中药组合物及其制备方法和用途 | |
CN104666999A (zh) | 一种降血压的中药配方 | |
CN109646665A (zh) | 杜仲清肺抗癌固体茶及其制备方法 | |
CN104436003B (zh) | 治疗小儿荨麻疹的中药药浴及其制备方法 | |
CN103007145A (zh) | 一种治疗小儿轮状病毒肠炎的中药组合物及其制备方法 | |
CN106106919A (zh) | 一种含有黄皮叶的保健茶饮料及其制备方法 | |
CN104189639A (zh) | 夏季感冒高烧解表退热药剂及制法 | |
CN105412643A (zh) | 一种治疗小儿水气凌心型哮喘的喷雾剂及其制备方法 | |
CN105012842A (zh) | 一种用于解酒的制剂及其制法 | |
CN105233093A (zh) | 一种治疗胃下垂的中药片剂 | |
CN104771530A (zh) | 一种治疗喘脱型心源性哮喘的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180119 |